Stocks
TherapeuticsMD, Inc.TXMDQ
HealthcareBiotechnology
A specialty pharmaceutical company focused on developing and commercializing products for women's healthcare, particularly hormone therapy and prenatal vitamins. Its lead products include Imvexxy and Bijuva, which address menopausal symptoms. Investors track the company due to its niche market focus and its Chapter 11 bankruptcy proceedings, which have affected its stock trading.
Congressional Interest in TherapeuticsMD, Inc. (TXMDQ)
1 member of Congress has disclosed 1 trade in TherapeuticsMD, Inc. (TXMDQ), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading TXMDQ?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-09-15 | James Comer | buy | $1K-$15K |